← Back to news
Clinical trialUNITERAREFriday, April 3, 2026 · April 3, 2026

New Recruiting Trial: Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

WHY IT MATTERS

This trial addresses a critical gap: African American cancer survivors are significantly underrepresented in genetic testing programs, meaning many miss opportunities for personalized cancer prevention and family screening.

Researchers are looking for African American cancer survivors to join a study about genetic testing. The study will test a new approach designed specifically for African American communities to help more people get tested for inherited cancer genes. Genetic testing can show if someone has genes that increase cancer risk, which helps with prevention and treatment planning.

NCT ID: NCT07436078 Title: Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors Status: RECRUITING Phase: NA Sponsor: Barbara Ann Karmanos Cancer Institute Start date: 2026-04-01 URL: https://clinicaltrials.gov/study/NCT07436078 Source: UniteRare clinical trials database

YOU CAN ACT ON THIS

If you are an African American cancer survivor, check the trial website (clinicaltrials.gov/study/NCT07436078) to see if you meet eligibility requirements and contact the Barbara Ann Karmanos Cancer Institute to learn about enrollment.

Find clinical trials →Learn more ↗
genetic testingcancer survivorshealth equityclinical trial recruitingafrican american health